Grant Program Overview

The Genzyme Renal Innovations Grant Program (GRIP) awards individual grants to researchers, clinicians and fellows in the field of Nephrology. GRIP was established to support the advancement of medical knowledge and practice in kidney diseases through innovative research projects in Nephrology. It represents the commitment Genzyme has made to enhance the care of patients with kidney disease. As we pursue new knowledge and understanding together, our hope is to sustain enduring research with the worldwide nephrology community.

Grants are awarded each year, with funding available for up to a maximum of $50,000 USD per year for a period of 1 to 3 years. A maximum of ten grants are awarded each year. All proposals are considered proprietary and confidential, and are not reproduced except for purposes of program administration.

GRIP Facts:

• GRIP kicked off in 2001
• A truly international program (82 recipients)
• North America - 42
• Latin America - 2
• EU - 35
• Asia Pacific - 3
• Over 11 M USD in grants awarded
• Over 58 publications generated